Related Experiment Videos
A malignant primary cardiac pheochromocytoma.
A Jirari1, A Charpentier, S Popescu
1Department of Cardiovascular Surgery, Hospital Civil de Strasbourg, France. jirari@cybercable.tm.fr
The Annals of Thoracic Surgery
|September 4, 1999
Summary
Malignant cardiac pheochromocytoma, a rare tumor, was treated with chemotherapy similar to neuroblastoma, achieving 5-year survival. Complete tumor resection is crucial due to unexpected malignancy potential.
Area of Science:
- Cardiology
- Oncology
- Endocrinology
Background:
- Malignant pheochromocytoma is a rare tumor with no established chemotherapy regimen.
- Primary cardiac pheochromocytoma is exceptionally rare.
Observation:
- A patient with malignant primary cardiac pheochromocytoma underwent surgical resection.
- Adjuvant cytotoxic chemotherapy, adapted from neuroblastoma treatment protocols, was administered post-surgery.
Findings:
- The patient achieved a 5-year survival following the combined treatment approach.
- The chemotherapy regimen, while not specific for pheochromocytoma, showed efficacy.
Implications:
- This case suggests a potential therapeutic strategy for malignant pheochromocytoma.
- Emphasizes the importance of complete and meticulous surgical resection for primary cardiac pheochromocytoma.
- Highlights the shared embryologic origin between pheochromocytoma and neuroblastoma as a basis for treatment selection.